Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J's Dx unit gets FDA ok for parathyroid hormone test

This article was originally published in Clinica

Executive Summary

Ortho Clinical Diagnostics' Vitros intact parathyroid hormone assay has received 510(k) clearance from the US FDA. The test is used to help diagnose hyperparathyroidism, hypoparathyroidism or hypercalcaemia of malignancy. Hyperparathyroidism, or overactivity of the parathyroid glands, causes excess calcium production which can lead to problems such as kidney stones and osteoporosis. The test can also determine whether surgery to remove a suspected parathyroid tumour has been successful. It can be run on several of Ortho's analysers, including the Vitros ECi/ECiQ, the 3600 immunodiagnostic system, or the 5600 integrated system, which allows clinical chemistry and immunoassay testing on one platform. The assay provides results in 18 minutes.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel